All aspects of the pharmaceutical industry are subject to stringent regulations, from clinical trials through to drug packaging. In fact, blister packs, bottles, and so on are among the most strictly controlled products deployed in global distribution networks. Drug containers are in near-constant contact with pharmaceutical products from the moment they are packaged to the time that they are consumed. Problems with thermodynamic stability or chemical inconsistencies can lead to contamination which may moderate therapeutic mechanisms of action, or worse, impart toxicity.
Pharmaceutical packaging testing is carried out to guarantee the suitability of drug packaging for its intended use. This encompasses all components containing the product, whether or not they are in direct contact with the drug. Details of packaging and storage demands for drug products are outlined in USP <659>, which focusses on the varied testing mechanisms suited for elastomeric, glass, and plastic container materials.
The rise of chronic diseases, an ageing global population, increased medication of emerging markets, and the global impact of the COVID-19 pandemic have been transformative for the pharmaceutical industry. Current market trends show exponential growth in novel drug approval year on year, with a growing variance in packaging materials. Regulatory pharmaceutical packaging testing for suitability is subsequently a matter of necessity.
Pharma Packaging Testing with Jordi Labs
Jordi Labs is a world-leader in specific regulatory testing. We have carried out a wide range of pharmaceutical studies to ensure that packaging systems never interact with drug products to compromise identity, safety, quality, purity, or strength. Download our recent publication if you would like to learn more. Or, contact a member of the Jordi Labs team today with any questions or requests.
